4,529 results on '"Pibarot, Philippe"'
Search Results
302. Impact of Classic and Paradoxical Low Flow on Survival After Aortic Valve Replacement for Severe Aortic Stenosis
303. Impact and Management of Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement
304. Amyloid Deposits in a Functionally Unicuspid Stenotic Aortic Valve
305. Carotid versus coronary atherosclerosis burdens in acute compared with chronic symptomatic coronary artery disease
306. Assessment of Aortic Stenosis Severity: Determining Timing to Surgery
307. Reappraisal of the Regurgitation Severity vs Left Ventricular Dilation Conceptual Framework for the Management of Secondary Mitral Regurgitation
308. Hemodynamic and Clinical Outcomes in Redo-Surgical Aortic Valve Replacement vs. Transcatheter Valve-in-Valve
309. Transcatheter Aortic Valve Implantation for Bioprosthetic Valve Failure: Placement of Aortic Transcatheter Valves 3 Aortic Valve-in-Valve Study
310. Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
311. Prevalence and Prognostic Implications of Moderate or Severe Mitral Regurgitation in Patients with Bicuspid Aortic Valve
312. Incidence, causes, correlates, and outcome of bioprosthetic valve dysfunction and failure following transcatheter aortic valve implantation
313. Institute Focus: Hypertension Research at Université Laval
314. TCT-517 Late Outcomes of Valve-in-Valve Transcatheter Aortic Valve Implantation vs Redo Surgical Aortic Valve Replacement: Meta-Analysis of Kaplan-Meier–Derived Individual Patient Data of Matched Studies
315. Late Outcomes of Permanent Pacemaker Implantation After TAVR: Meta-analysis of Reconstructed Time-to-Event Data
316. Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease
317. TCT-462 Impact of Paravalvular Leak on Outcomes After TAVR: Meta-Analysis of Kaplan-Meier–Derived Individual Patient Data
318. TCT-506 First Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement: From Bench Evaluation to First-in-Human Procedures
319. Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial
320. Live longer and better without aortic valve stenosis
321. Transvalvular Pressure Gradients and All-Cause Mortality Following TAVR
322. TCT-519 Timing of Bioprosthetic Valve Fracture in Transcatheter Valve-in-Valve Intervention: Impact on Valve Durability and Leaflet Integrity
323. Significance of Left Ventricular Ejection Time in Primary Mitral Regurgitation
324. TCT-457 Outcomes of Prosthesis–Patient Mismatch After Transcatheter Aortic Valve Implantation: A Meta-Analysis of Kaplan-Meier–Derived Individual Patient Data
325. Impact of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
326. European survey on valvular heart disease clinical experience from the European Society of Cardiology council on valvular heart disease
327. Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes
328. Characteristics of Trabeculated Myocardium Burden in Young and Apparently Healthy Adults
329. Comparison of Hemodynamic Performance of the Balloon-Expandable SAPIEN 3 Versus SAPIEN XT Transcatheter Valve
330. Impact of Aortic Valve Calcification, as Measured by MDCT, on Survival in Patients With Aortic Stenosis: Results of an International Registry Study
331. Evaluation of aortic stenosis severity using 4D flow jet shear layer detection for the measurement of valve effective orifice area
332. Clinical Impact of Aortic Regurgitation After Transcatheter Aortic Valve Replacement: Insights Into the Degree and Acuteness of Presentation
333. Outcomes With Post-Dilation Following Transcatheter Aortic Valve Replacement: The PARTNER I Trial (Placement of Aortic Transcatheter Valve)
334. P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: Implication for calcific aortic valve disease
335. Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated With Decreased Hospitalizations
336. Long-Term Prognostic Value and Serial Changes of Plasma N-Terminal Prohormone B-Type Natriuretic Peptide in Patients Undergoing Transcatheter Aortic Valve Implantation
337. Mechanical strain induces the production of spheroid mineralized microparticles in the aortic valve through a RhoA/ROCK-dependent mechanism
338. Doppler Vortography: A Color Doppler Approach to Quantification of Intraventricular Blood Flow Vortices
339. Reply to Trimaille et al.—Association Between Prosthesis-Patient Mismatch and Valve Thrombosis: An Independent Link?
340. Prosthetic Valve Dysfunction
341. The Emerging Role of Exercise Testing and Stress Echocardiography in Valvular Heart Disease
342. Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement
343. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement
344. Multiple and Mixed Valvular Heart Diseases: Pathophysiology, Imaging, and Management
345. Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study
346. Computed Tomography Aortic Valve Calcium Scoring in Patients With Aortic Stenosis
347. Blood, tissue and imaging biomarkers in calcific aortic valve stenosis: past, present and future
348. Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves
349. Exercise Hemodynamic and Functional Capacity After Mitral Valve Replacement in Patients With Ischemic Mitral Regurgitation: A Comparison of Mechanical Versus Biological Prostheses
350. Outcome of aortic valve replacement in aortic stenosis: the number of valve cusps matters
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.